The Faces of Luminex: Jen Dillman, Product Development
There are a lot of steps between having the idea for a new product and actually making the product for commercial release. Here at Luminex, we count on people like Jen Dillman, Senior Manager of Product Development, to help get new products across the finish line. She joined our Wisconsin-based team in 2009 and earned
Continue reading »
The Faces of Luminex: Heather Darby, LTG Field Applications
The partners who develop new assays based on our xMAP® Technology through Luminex’s Licensed Technologies Group (LTG) are incredibly dedicated and creative — but even they need help with applications development from time to time. That’s where Heather Darby, Field Applications Scientist, comes in. She joined Luminex in 2015 and holds bachelor and master degrees
Continue reading »
Meet Ankit Patel, QuantiGene™ Assay Developer at Thermo Fisher Scientific
Plus: 6 tips for QuantiGene assays When you want an assay that can detect nucleic acids, you’ll likely choose the high-quality Invitrogen™ ProcartaPlex™ and QuantiGene™ Plex assays from Thermo Fisher Scientific, a Luminex partner. The QuantiGene assay uses branched DNA (bDNA) technology, relying on signal amplification instead of target amplification for optimal quantitation of transcripts.
Continue reading »
Querying RAS: How a Multiplex Assay Became a Robust Transcriptional Readout for HTS
In Q&A, scientists describe development and offer multiplexing tips A few years ago, scientists at Merck & Co were looking for a better way to evaluate the activity of the RAS-MAPK pathway, which is particularly important for cancer development and can also signal susceptibility or resistance to emerging therapies. They used the Thermo Fisher QuantiGene™
Continue reading »
The Faces of Luminex: Feng Sun, Bioinformatics
When you get a result from your VERIGENE® assay, what you don’t see is the expertise in bioinformatics and data science that went into designing the assays, setting just the right threshold, analyzing each target for optimal performance, and telling the software how to report the information to you. But you can bet that Feng
Continue reading »
xMAP®-powered Assay Provides Critical Clues from Liquid Biopsy Samples
14-gene assay interrogates circulating tumor cells Liquid biopsies are opening new avenues for cancer research and diagnosis, but even experts in the field continue to nail down the best protocols for analyzing the cell-free DNA and circulating tumor cells (CTCs) contained in these peripheral blood samples. Evi Lianidou, professor of Analytical Chemistry and Clinical Chemistry
Continue reading »
The Faces of Luminex: Irene Adams, Sales Operations & Effectiveness
When our sales reps are eager to find out how much they’ve earned in commissions, there’s one person they contact: Irene Adams, Senior Compensation Analyst. She calculates everyone’s commissions and also helps shape compensation plans for best results. A native of Bavaria, Germany, she joined Luminex in 2010 and holds a bachelor’s degree in finance
Continue reading »
Show Your Rare: Help Us Raise Awareness for People Affected by Rare Diseases
February 28 is Rare Disease Day Here at Luminex, we are big fans of Rare Disease Day. Celebrated annually on the last day of February, this day is not just a reminder that we can all be doing more to support patients with rare diseases as well as the caregivers, scientists and clinicians who work
Continue reading »
Five Things We Learned from an xMAP® Power User
DKFZ’s Tim Waterboer has published more xMAP papers than any other user At the fourth annual xMAP® Connect user group meeting held in Amsterdam late last year, we had the good fortune of sitting down with Tim Waterboer, PhD, leader of the Infections and Cancer Epidemiology Group at DKFZ, the German Cancer Research Center. Waterboer
Continue reading »
The Faces of Luminex: Carrie Prehoda, Accounting
Keeping the financial statements for any company is a critical job, but especially so for a publicly traded firm like Luminex that has to report its finances to the U.S. Securities and Exchange Commission. We trust our data to Carrie Prehoda, Manager of Accounting and Stock Plan Administration, who joined the company in 2016. She’s
Continue reading »